Duggan M, Jochems C, Donahue R, Richards J, Karpa V, Foust E
Cancer Immunol Immunother. 2016; 65(11):1353-1364.
PMID: 27581603
PMC: 5071149.
DOI: 10.1007/s00262-016-1893-7.
Jordinson M, El-Hariry I, CALNAN D, Calam J, Pignatelli M
Gut. 1999; 44(5):709-14.
PMID: 10205210
PMC: 1727505.
DOI: 10.1136/gut.44.5.709.
Nomoto K, Tomita N, Miyake M, Xhu D, LoGerfo P, Weinstein I
Jpn J Cancer Res. 1999; 89(12):1257-66.
PMID: 10081486
PMC: 5921740.
DOI: 10.1111/j.1349-7006.1998.tb00522.x.
Ker C, SHEEN P, Chien C, Wu C
Surg Today. 1993; 23(6):496-9.
PMID: 8358193
DOI: 10.1007/BF00730623.
Buley I
J Clin Pathol. 1993; 46(10):881-5.
PMID: 8227400
PMC: 501610.
DOI: 10.1136/jcp.46.10.881.
Is tissue polypeptide antigen more accurate than serum CEA for diagnosing pancreatic cancer?.
Panucci A, Fabris C, Del Favero G, Basso D, Di Mario F, Marchioro L
J Clin Pathol. 1986; 39(1):75-7.
PMID: 3950034
PMC: 499616.
DOI: 10.1136/jcp.39.1.75.
Non-specific cross-reacting antigen (NCA) in individual maturation stages of myelocytic cell series.
Noworolska A, Harlozinska A, Richter R, Brodzka W
Br J Cancer. 1985; 51(3):371-7.
PMID: 3882113
PMC: 1976944.
DOI: 10.1038/bjc.1985.49.
Application of a subcellular membrane-antibody binding assay for the analysis of antigen expression in human tumours.
Price M, Edwards S, Baldwin R
J Cancer Res Clin Oncol. 1986; 111(2):169-72.
PMID: 3700463
DOI: 10.1007/BF00400759.
CEA-containing immune complexes in sera of patients with colorectal and breast cancer--analysis of complexed immunoglobulin classes.
Fuchs C, Krapf F, Kern P, Hoferichter S, Jager W, Kalden J
Cancer Immunol Immunother. 1988; 26(2):180-4.
PMID: 3282655
PMC: 11041060.
DOI: 10.1007/BF00205613.
Release of carcinoembryonic antigen from human colon cancer cells by phosphatidylinositol-specific phospholipase C.
Sack T, GUM J, Low M, Kim Y
J Clin Invest. 1988; 82(2):586-93.
PMID: 3042807
PMC: 303552.
DOI: 10.1172/JCI113636.
Monoclonal antibodies against CEA-related components discriminate between pancreatic duct type carcinomas and nonneoplastic duct lesions as well as nonduct type neoplasias.
Batge B, Bosslet K, Sedlacek H, Kern H, Kloppel G
Virchows Arch A Pathol Anat Histopathol. 1986; 408(4):361-74.
PMID: 3004013
DOI: 10.1007/BF00707694.
Carcinoembryonic antigen: function in metastasis by human colorectal carcinoma.
Jessup J, Thomas P
Cancer Metastasis Rev. 1989; 8(3):263-80.
PMID: 2697474
DOI: 10.1007/BF00047341.
Quantitative considerations supporting the irrelevance of circulating serum CEA for the immunoscintigraphic visualization of CEA expressing carcinomas.
Bosslet K, Steinstrasser A, Schwarz A, Harthus H, Luben G, Kuhlmann L
Eur J Nucl Med. 1988; 14(11):523-8.
PMID: 2463168
DOI: 10.1007/BF00286769.
Epitopes of carcinoembryonic antigen (CEA) defined by monoclonal antibodies.
Price M
Br J Cancer. 1988; 57(2):165-9.
PMID: 2451932
PMC: 2246432.
DOI: 10.1038/bjc.1988.34.
Mapping of monoclonal antibody-defined epitopes associated with carcinoembryonic antigen, CEA.
Price M, Edwards S, Jacobs E, Pawluczyk I, Byers V, Baldwin R
Cancer Immunol Immunother. 1987; 25(1):10-5.
PMID: 2439201
PMC: 11038482.
DOI: 10.1007/BF00199295.
Markers and characteristics of human SCLC cell lines. Neuroendocrine markers, classical tumor markers, and chromosomal characteristics of permanent human small cell lung cancer cell lines.
Bepler G, Jaques G, Koehler A, Gropp C, Havemann K
J Cancer Res Clin Oncol. 1987; 113(3):253-9.
PMID: 2438285
DOI: 10.1007/BF00396382.
Mapping epitope characteristics on carcinoembryonic antigen.
Harwood P, Britton D, Southall P, Boxer G, Rawlins G, Rogers G
Br J Cancer. 1986; 54(1):75-82.
PMID: 2425837
PMC: 2001645.
DOI: 10.1038/bjc.1986.154.
Carcinoembryonic antigen functions as an accessory adhesion molecule mediating colon epithelial cell-collagen interactions.
Pignatelli M, Durbin H, Bodmer W
Proc Natl Acad Sci U S A. 1990; 87(4):1541-5.
PMID: 2304917
PMC: 53511.
DOI: 10.1073/pnas.87.4.1541.
